Friday, 19 April 2024
Sonoma Pharmaceuticals Inc.
NASDAQ : SNOA
1.900 14 Oct 22 00:00 | Change: 0.04 | Open: 1.940 | High: 1.970 | Ask: 0.000 | Volume: 8,200 |
Change(%): 1.99 | Prev: 1.939 | Low: 1.860 | Bid: 0.000 | Avg vol: 0 |
01:00 | 10/3/18
GlobeNewswire
Sonoma Pharmaceuticals is a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care.
more»
13:22 | 7/3/18
GlobeNewswire
Copies of the final prospectus supplement and accompanying prospectus are available on the SEC's website at www.sec.gov, or may be obtained by contacting Dawson James Securities, Inc., Attention: Prospectus Department, 1 North Federal Highway, 5th ...
more»
10:00 | 8/2/18
GlobeNewswire
PETALUMA, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA, warrants SNOAW), a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions ...
more»
PETALUMA, Calif., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA, warrants SNOAW) today announced that financial results for its fiscal third quarter 2018, ended December 31, 2017, will be released after the U.S.
more»
01:11 | 24/1/18
The Ledger Gazette
Zacks Investment Research cut shares of Sonoma Pharmaceuticals (NASDAQ:SNOA) from a buy rating to a hold rating in a research note released on Thursday, January 11th.
more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
|
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |